Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) CEO Sells $16,440.78 in Stock
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,278 shares of the firm’s stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $1.01, for a total transaction of $16,440.78. Following the completion of the transaction, the chief executive officer now directly […]
More Stories
World News in Brief: Mpox update, Haiti displacement, deadly strikes in Ukraine, Pakistan attack condemned
The mpox outbreak continues to constitute a public health emergency of international concern, the World Health Organization (WHO) said in...
Matt Gaetz Says He’s Not Returning to Congress Next Year
By Jack Phillips Former Florida Congressman Matt Gaetz on Friday responded to speculation that he could return to the U.S....
Economic Optimism Rises as Business Activity Soars to 31-Month High
By Tom Ozimek Business activity in the United States surged in November to its highest level in nearly three years,...
Children and amputees bear brunt of Myanmar’s deadly landmine epidemic
Myanmar has become the world’s deadliest country for landmine and unexploded ordnance casualties, with over 1,000 victims in 2023 alone,...
Integrated Investment Consultants LLC Acquires Shares of 1,840 The Trade Desk, Inc. (NASDAQ:TTD)
Integrated Investment Consultants LLC bought a new position in The Trade Desk, Inc. (NASDAQ:TTD – Free Report) during the third...
Navellier & Associates Inc. Purchases New Position in Fortinet, Inc. (NASDAQ:FTNT)
Navellier & Associates Inc. bought a new stake in shares of Fortinet, Inc. (NASDAQ:FTNT – Free Report) during the 3rd...